BALLIET JENNIFER 4
4 · NEOGENOMICS INC · Filed Nov 18, 2019
Insider Transaction Report
Form 4
BALLIET JENNIFER
Vice President of HR
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2019-11-15−6,667→ 20,000 totalExercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (6,667 underlying) - Exercise/Conversion
Common Stock
2019-11-15$8.03/sh+166$1,333→ 29,695 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-15−166→ 48,334 totalExercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (166 underlying) - Exercise/Conversion
Common Stock
2019-11-15$7.52/sh+6,667$50,136→ 29,529 total - Sale
Common Stock
2019-11-15$23.45/sh−6,833$160,234→ 22,862 total
Holdings
- 17,496
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (17,496 underlying)
Footnotes (3)
- [F1]On April 28, 2017, Jennifer Balliet was granted 60,000 stock options which vest ratably over the first three anniversary dates of the grant date.
- [F2]On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vest ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Jennifer Balliet was granted 17,496 stock options which vest ratably over the first four anniversary dates of the grant date.